Alterations in the antagonism by naloxone of morphine-induced respiratory depression and analgesia after morphine pretreatment
- PMID: 731438
Alterations in the antagonism by naloxone of morphine-induced respiratory depression and analgesia after morphine pretreatment
Abstract
Mice were pretreated either acutely or chronically with morphine to test the effect of such pretreatments on the antagonism by naloxone of morphine-induced respiratory depression and analgesia and to compare the development of tolerance to the two effects. A s.c. injection of 20 mg/kg of morphine 6 hr before testing produced a shift of the apparent pA2 of morphine-naloxone for analgesia from 7.05 to 7.33, while the same pretreatment did not change the apparent pA2 for respiratory depression. However, s.c. implantation of a morphine pellet for 72 hr produced a shift in the apparent pA2 of morphine-naloxone for respiratory depression from 7.35 to 7.63, which represents less than a 2-fold increase in naloxone potency. The same pretreatment produced a further shift of the apparent pA2 for analgesia to 7.58, representing a greater than 3-fold increase in naloxone potency. After morphine pellet implantation mice showed a much greater degree of tolerance to morphine-induced analgesia than to respiratory depression. These results provide further evidence that narcotic-induced respiratory depression and analgesia are mediated by different receptor interactions.
Similar articles
-
Antagonism by naloxone of narcotic-induced respiratory depression and analgesia.J Pharmacol Exp Ther. 1978 Nov;207(2):494-503. J Pharmacol Exp Ther. 1978. PMID: 30841
-
Enhanced naloxone distribution to the brain by morphine pretreatment in mice.Drug Metab Dispos. 1977 Mar-Apr;5(2):167-73. Drug Metab Dispos. 1977. PMID: 15809
-
Potency, duration of action and pA2 in man of intravenous naloxone measured by reversal of morphine-depressed respiration.J Pharmacol Exp Ther. 1981 Oct;219(1):156-62. J Pharmacol Exp Ther. 1981. PMID: 7288605 Clinical Trial.
-
The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone.Clin Pharmacokinet. 1976;1(3):219-30. doi: 10.2165/00003088-197601030-00004. Clin Pharmacokinet. 1976. PMID: 13957 Review.
-
Influence of anaesthesia and analgesia on the control of breathing.Br J Anaesth. 2003 Jul;91(1):40-9. doi: 10.1093/bja/aeg150. Br J Anaesth. 2003. PMID: 12821564 Review. No abstract available.
Cited by
-
Co-activation of μ- and δ-opioid receptors elicits tolerance to morphine-induced ventilatory depression via generation of peroxynitrite.Respir Physiol Neurobiol. 2013 May 1;186(3):255-64. doi: 10.1016/j.resp.2013.02.028. Epub 2013 Mar 5. Respir Physiol Neurobiol. 2013. PMID: 23473921 Free PMC article.
-
Differential mechanisms in the acquisition and expression of heroin-induced place preference.Psychopharmacology (Berl). 1989;98(1):61-7. doi: 10.1007/BF00442007. Psychopharmacology (Berl). 1989. PMID: 2498960
-
Effects of acute morphine pretreatment on the rate-decreasing and antagonist activity of naloxone.Psychopharmacology (Berl). 1986;88(2):201-8. doi: 10.1007/BF00652241. Psychopharmacology (Berl). 1986. PMID: 3081932
-
Ethanol Reversal of Tolerance to the Respiratory Depressant Effects of Morphine.Neuropsychopharmacology. 2016 Feb;41(3):762-73. doi: 10.1038/npp.2015.201. Epub 2015 Jul 14. Neuropsychopharmacology. 2016. PMID: 26171718 Free PMC article.
-
Mitragynine and 7-Hydroxymitragynine: Bidirectional Effects on Breathing in Rats.bioRxiv [Preprint]. 2025 May 21:2025.05.16.654392. doi: 10.1101/2025.05.16.654392. bioRxiv. 2025. PMID: 40475626 Free PMC article. Preprint.